Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で41.97%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 14.16Mに達しています。
黒字転換
同社は黒字転換を果たし、最新の年間純利益はUSD 74.00Kです。%!(EXTRA int=2)
割高
同社の最新のPEは33.27で、過去3年間の水準と比較して高値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は5.84M株で、前四半期比で3.04%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を323.44K株保有しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は1.63です。